Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Automated Inhaler Testing

By Drug Discovery Trends Editor | May 21, 2010

Astech Projects has added the automated Waste Firer System to its range of Xelair Series analyst workstations for inhaler testing. The new Xelair 1 Waste Firer automates the device preparation, actuation and waste dose collection, including sonic flow confirmation, in the QA of inhaler production and product development.

Manual, labor-intensive and time-consuming waste firing is a requirement for many inhaler tests and exposes operators to risks of repetitive strain injury (RSI), work-related upper limb disorder and also possible inhalation of the active pharmaceutical ingredient. By automating this process, the Xelair 1 Waste Firer leads to a significant reduction in these Health and Safety issues, as well as increasing productivity and reducing result variability.

The Xelair 1 Waste Firer can automate device cap removal, actuation and waste dose collection, and is compatible with most device types including dry powder inhalers (DPI), metered dose inhalers (MDI) and breath-actuated inhalers (BAI), with an optional shaking system for MDIs. Operating at a high throughput of up to 360 collections per hour dependent on the device, the standard unit holds ten inhaler devices, but can be tailored to suit individual customer requirements. The waste dose collector, which incorporates filtration and safe collection sump has a very high capacity, so only infrequent disposal is required.

Astech Projects


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE